NO20050961L - R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning - Google Patents
R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkningInfo
- Publication number
- NO20050961L NO20050961L NO20050961A NO20050961A NO20050961L NO 20050961 L NO20050961 L NO 20050961L NO 20050961 A NO20050961 A NO 20050961A NO 20050961 A NO20050961 A NO 20050961A NO 20050961 L NO20050961 L NO 20050961L
- Authority
- NO
- Norway
- Prior art keywords
- amino
- alkyl
- hydroxypropanoic acid
- gem
- diphenyl
- Prior art date
Links
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title abstract 6
- 239000004471 Glycine Substances 0.000 title abstract 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N serine Chemical class OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 title abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 239000004305 biphenyl Substances 0.000 abstract 3
- 206010003805 Autism Diseases 0.000 abstract 2
- 208000020706 Autistic disease Diseases 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000001118 alkylidene group Chemical group 0.000 abstract 2
- 230000005540 biological transmission Effects 0.000 abstract 2
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 201000000980 schizophrenia Diseases 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- -1 N, N-disubstituted lysinoyl Chemical group 0.000 abstract 1
- 125000001980 alanyl group Chemical class 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0210306A FR2843590B1 (fr) | 2002-08-14 | 2002-08-14 | Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique |
PCT/FR2003/002447 WO2004016580A2 (fr) | 2002-08-14 | 2003-08-01 | Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050961L true NO20050961L (no) | 2005-04-28 |
Family
ID=30775996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050961A NO20050961L (no) | 2002-08-14 | 2005-02-23 | R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning |
Country Status (19)
Country | Link |
---|---|
US (1) | US7488755B2 (fr) |
EP (1) | EP1529030A2 (fr) |
JP (1) | JP2005535715A (fr) |
KR (2) | KR100756138B1 (fr) |
CN (1) | CN1675169A (fr) |
AU (1) | AU2003274213B2 (fr) |
BR (1) | BR0313740A (fr) |
CA (1) | CA2497347A1 (fr) |
CR (1) | CR7736A (fr) |
EA (1) | EA010417B1 (fr) |
FR (1) | FR2843590B1 (fr) |
GE (1) | GEP20074194B (fr) |
IL (1) | IL166778A0 (fr) |
MX (1) | MXPA05001761A (fr) |
NO (1) | NO20050961L (fr) |
NZ (1) | NZ538633A (fr) |
PL (1) | PL375413A1 (fr) |
UA (1) | UA80559C2 (fr) |
WO (1) | WO2004016580A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013072936A2 (fr) * | 2011-11-10 | 2013-05-23 | Ramamohan Rao Davuluri | Procédé inédit de préparation de (r)-n-benzyl-2-acétamido-3-méthoxypropionamide |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03236315A (ja) * | 1989-12-05 | 1991-10-22 | Nippon Oil & Fats Co Ltd | 抗精神病薬 |
US5332758A (en) * | 1990-07-13 | 1994-07-26 | Kanebo, Ltd. | Collagen metabolism ameliorant and its use |
ES2036926B1 (es) * | 1991-08-08 | 1994-01-16 | Uriach & Cia Sa J | "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina". |
GB9425730D0 (en) | 1994-12-20 | 1995-02-22 | Nycomed Pharma As | Compounds |
PT871440E (pt) * | 1995-12-07 | 2006-07-31 | Daniel C Javitt | Tratamento de sintomas negativos e cognitivos de esquizofrenia com antagonistas da captacao de glicina |
IT1283489B1 (it) * | 1996-07-23 | 1998-04-21 | Chiesi Farma Spa | Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico |
RU2219924C2 (ru) * | 1998-04-14 | 2003-12-27 | Дзе Дженерал Хоспитал Корпорейшн | Способ лечения нейропсихиатрических расстройств |
GB2410947B (en) | 2004-02-11 | 2008-09-17 | Cambridge Lab Ltd | Pharmaceutical compounds |
-
2002
- 2002-08-14 FR FR0210306A patent/FR2843590B1/fr not_active Expired - Fee Related
-
2003
- 2003-01-08 UA UAA200501927A patent/UA80559C2/uk unknown
- 2003-08-01 CN CNA038188481A patent/CN1675169A/zh active Pending
- 2003-08-01 AU AU2003274213A patent/AU2003274213B2/en not_active Ceased
- 2003-08-01 EP EP03758195A patent/EP1529030A2/fr not_active Withdrawn
- 2003-08-01 KR KR1020057002073A patent/KR100756138B1/ko not_active IP Right Cessation
- 2003-08-01 JP JP2004528582A patent/JP2005535715A/ja active Pending
- 2003-08-01 GE GEAP8683A patent/GEP20074194B/en unknown
- 2003-08-01 US US10/524,869 patent/US7488755B2/en not_active Expired - Fee Related
- 2003-08-01 BR BR0313740-6A patent/BR0313740A/pt not_active IP Right Cessation
- 2003-08-01 WO PCT/FR2003/002447 patent/WO2004016580A2/fr active Application Filing
- 2003-08-01 KR KR1020077013426A patent/KR100890674B1/ko not_active IP Right Cessation
- 2003-08-01 CA CA002497347A patent/CA2497347A1/fr not_active Abandoned
- 2003-08-01 NZ NZ538633A patent/NZ538633A/en not_active IP Right Cessation
- 2003-08-01 MX MXPA05001761A patent/MXPA05001761A/es active IP Right Grant
- 2003-08-01 EA EA200500333A patent/EA010417B1/ru not_active IP Right Cessation
- 2003-08-01 PL PL03375413A patent/PL375413A1/xx unknown
-
2005
- 2005-02-09 IL IL16677805A patent/IL166778A0/xx unknown
- 2005-02-23 NO NO20050961A patent/NO20050961L/no not_active Application Discontinuation
- 2005-03-11 CR CR7736A patent/CR7736A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2003274213B2 (en) | 2008-03-13 |
FR2843590A1 (fr) | 2004-02-20 |
FR2843590B1 (fr) | 2007-10-05 |
WO2004016580A2 (fr) | 2004-02-26 |
KR100890674B1 (ko) | 2009-03-26 |
GEP20074194B (en) | 2007-09-10 |
UA80559C2 (en) | 2007-10-10 |
US20050261372A1 (en) | 2005-11-24 |
IL166778A0 (en) | 2006-01-15 |
JP2005535715A (ja) | 2005-11-24 |
KR20070067250A (ko) | 2007-06-27 |
NZ538633A (en) | 2007-10-26 |
AU2003274213A1 (en) | 2004-03-03 |
WO2004016580A3 (fr) | 2004-04-08 |
EA200500333A1 (ru) | 2005-08-25 |
CN1675169A (zh) | 2005-09-28 |
KR100756138B1 (ko) | 2007-09-05 |
KR20050055697A (ko) | 2005-06-13 |
EA010417B1 (ru) | 2008-08-29 |
CA2497347A1 (fr) | 2004-02-26 |
US7488755B2 (en) | 2009-02-10 |
CR7736A (es) | 2008-10-10 |
PL375413A1 (en) | 2005-11-28 |
MXPA05001761A (es) | 2005-04-25 |
EP1529030A2 (fr) | 2005-05-11 |
BR0313740A (pt) | 2005-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
NO20065878L (no) | Terapeutiske forbindelser | |
NO20052914L (no) | Terapeutiske forbindelser | |
BR0015624A (pt) | Uso de um composto, composto, composição farmacêutica, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
BRPI0413695A (pt) | derivados de naftiridina substituìda como inibidores do fator inibidor da migração de macrófagos e seu uso no tratamento de doenças humanas | |
NO20062370L (no) | Amidderivater | |
AU2003225617A1 (en) | Thiadiazolylpiperazine derivatives useful for treating or preventing pain | |
MA27702A1 (fr) | Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation | |
NO20076319L (no) | Farmasoytiske sammensetninger av et neuroaktivt steroid og anvendelse derav | |
YU74500A (sh) | Novi derivat 3-aril-2-hidroksipropionske kiseline (i) | |
MY138352A (en) | Benzothiazole derivatives | |
MX9707453A (es) | Derivados de quinazolina. | |
MY136761A (en) | Oxazol derivatives | |
NO20045222L (no) | Benzosyrederivater som modulatorer av PPAR alfa og gamma | |
ES2098947T3 (es) | Derivados de beta,beta-dimetil-4-piperidinoetanamina como inhibidores de la biosintesis del colesterol. | |
UA89067C2 (ru) | Производные гидантоина, полезные как ингибиторы металлопротеиназ | |
CA2302568A1 (fr) | Procede, compositions et trousses servant a augmenter la biodisponibilite orale d'agents pharmaceutiques | |
BRPI0413013A (pt) | composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças | |
ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
HUP0104963A2 (hu) | Bőrbetegségek kezelésére szolgáló készítmények | |
HK1058515A1 (en) | Use of pamoic acid for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates. | |
HUP0100102A2 (hu) | Fenil-amino-alkilkarbonsav-származékok és fenil-amino-alkilkarbonsav-származékokat tartalmazó gyógyszerészeti készítmények | |
HUP0104308A2 (hu) | Amidino- és guanidino-azetidinon-származékok, mint triptáz inhibitorok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek | |
NO20050961L (no) | R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning | |
NO20076683L (no) | Cyanopyrrol-sulfonamid progesteron reseptormodulatorer og deres anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |